• Search
  • Helpdesk
  • Sales contact
Get your demo

Press Release

Kayentis accelerates US growth with 40% surge in bookings over the last year and major Top Pharma wins – Amy Jones appointed Chief Commercial Officer to amplify and sustain expansion

Kayentis deploys a record US expansion in 2025 driven by strategic partnerships; new Chief Commercial Officer (CCO) Amy Jones will further propel growth and deepen biotech, key pharma, and CRO...

Kayentis introduces its Patient Education Video Library to strengthen clinical trial engagement and compliance

Patient engagement
Co-created with patient advocates and integrated into the Kayentis electronic Clinical Outcome Assessment (eCOA) application, patient educational videos enrich Kayentis’...

Kayentis enlists experts in oncology, neurodegenerative and metabolic disorders to form scientific advisory board

Board’s specialties in rare diseases, oncology, neurosciences, cardiology and metabolic disorders drive Kayentis’ expertise further in aiding pharma and biotech...

Kayentis raises further €5M to boost US activities

Additional funds will be used to scale-up Kayentis’ operations in North America to support clinical trials Grenoble, France, March 28,...

Kayentis and ClinOne join forces to improve efficiency and patient experience in clinical trials

eConsent
Alliance merges products and services, gaining patients, sites and sponsors unique access to best-in-class eCOA, eConsent and patient engagement solutions.Single...
Default Image

Kayentis launches fully integrated platform for decentralized clinical trials

Grenoble, France, March 23, 2022 - Kayentis, a global provider of eCOA and Decentralized Clinical Trial solutions, today announces the...
Default Image

Press Release // Kayentis raises €7M ($8.3M) to accelerate the global expansion of its digital platform for clinical trials

Funds will strengthen Kayentis’ digitalization approach in transforming how pharma, investigator sites and patients engage in clinical trials Grenoble, France,...

Press Release // Kayentis launches new initiatives to bolster carbon-neutral clinical trials

CSR
Carbon-neutral program takes aim at reducing CO2 emissions in clinical trials, particularly phase III, without impacting their cost, quality or...

Press Release // Kayentis forges ahead on five new eCOA service projects with emerging biopharma firms in Europe and US

Kayentis sets up incoming EBPs, major contributors in biomedical innovation, as well as its existing clients, with contingency plans to...

Press Release // Kayentis opens Japanese subsidiary to support growth of Asia-Pacific clinical trials sector

Proximity will facilitate local and international sponsor access to Kayentis’ eCOA services for mid- to later-stage clinical trials Kayentis will...
Default Image

Press Release // Kayentis appoints Estelle Haenel as medical director

Scientific advice
25-year pharma industry veteran and clinical trials expert will strengthen Kayentis’ eCOA offering to sponsors seeking to use digital patient-facing...

Support from Bpifrance & Europe

We are proud to announce that Kayentis has received support from Bpifrance & Europe for the development and industrialization of...

Kayentis, a global expert in eCOA, is strenghening its US presence

Kayentis, expert in eCOA, is stengthening its presence in the US and opening offices in Boston. Guillaume Juge, Kayentis CEO...

Kayentis Partners with OmniComm to Offer Integrated EDC and eCOA Solutions

        Fort Lauderdale, FL - OmniComm Systems, Inc. (OTCQX: OMCM), a leading global provider of clinical data...

Kayentis announces the release of its new eCOA solution, Clin’form3 Suite

A multi-platform eCOA solution to address the clinical trial needs of the future Over the last 2 years, Kayentis has...

Kayentis signs up 5 new phase III clinical studies

These phase III clinical studies, supported by Top10 pharma laboratories, will be using the tablet-based data capture solution developed by...
Follow us on social media
Subscribe to our newsletter
You may also like

Kayentis accelerates US growth with 40% surge in bookings over...

Empowering patients through education – A structured approach to clinical...

Kayentis introduces its Patient Education Video Library to strengthen clinical...

Expanding investor confidence: The strategic value of Patient Reported Outcomes...

Leveraging the potential of Patient Reported Outcome (PRO) data to...

Gastrointestinal Tract Diseases Research: Moving Towards Patient-Centered Clinical Trials

About the author
Picture of Marc Chaperon

Marc Chaperon

Estelle brings 20+ years of experience in pre-clinical and clinical research from Top 5 Pharma and Biotech firms. Leading projects across Phases 1 to 4 in diverse therapeutic areas, she offers deep insights into clinical science, operations, and regulatory intricacies. Appointed as Chief Medical Officer at Kayentis in May 2019.